Metropolis Healthcare Limited is coming soon to introduce at stock exchange platform for trading in Secondary market. Interested clients can retrieve details like Price Band and Dates of the IPO, Company Profile, Allotment Status, Listing Dates etc. The firm has drafted a Red Herring Prospectus and got approval for the same from the Regulatory firm Securities Board of India. The IPO is scheduled for Apr 3, 2019 with a price band of Rs. 877- Rs.880 per equity share. The lot size of applying the IPO is for 17 shares. One can apply via ASBA to avail the benefit of listing this IPO. The maximum application of amount for retail investor stood at Rs. 2 lacs.

Company Profile:-

The company was incorporated  on January 1980 in Maharashtra, Mumbai. It is well known as a diagnosis company in India. The firm operates widely in the field of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. It  also facilitates to clinical research organizations for their clinical research projects. It has its presence across 18 states and 173 cities to monitor the diseases, early detection, and diagnostic screening. As per the record of financial year 2018, it has successfully  executed approximately 16.0 million tests from approximately 7.7 million patient visits. MHL has implemented and introduced a ‘hub and spoke’ model for quick and efficient delivery of services through its widespread laboratory and service centers. It runs approx. 3480 clinical laboratory tests and 524 profiles including a variety of test combinations mainly for a disease or disorder along with wellness profiles that are used for health and fitness screening.

The firm tests under given categories like:-

1) ‘Routine’ tests such as blood chemistry analyses, blood cell counts and urine examination;

2) ‘Semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests;

3) ‘Specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics.         

Positive Outlook Of The Firm:

  1. Well known brand and foremost towards in the Indian diagnostics industry,
  2. Follow robust functional and operational network,
  3. Comprehensive test menu with wide range of clinical laboratory tests and profiles,
  4. Focus on quality and customer service,
  5. Use a higher Information Technology Infrastructure with Focus on Improving Efficiency,
  6. Maintain a consistence track record of successful acquisition and integration in India and overseas.

Objects Of The Issue:-

Below are the objects of the issue:-

  1. To avail the advantages of listing the Equity Shares on the Stock Exchanges for the offer for sale.

2.To enhance and improve the visibility and brand image and provide liquidity to its Shareholders.

Summary Of Issue:

Issue Open:- Apr 3, 2019, Apr 5, 2019
Issue Type  Book Built Issue IPO
Issue Size (Value) 15,269,684 Equity Shares of Rs. 10 (aggregating up to Rs. 1343.73 Cr)
Face Value Rs. 2 Per Equity Share
Issue Price Rs. [877-880] Per Equity Share
Market lots  17 Shares
Minimum Order Quantity 17 Shares
Listing At BSE, NSE

(*) indicates to be updated)

Get Upcoming IPO Notification on your mobile, Download our App



Metropolis Healthcare Limited IPO Subscription Details

Category No.of shares offered/reserved No. of shares bid for No. of times of total meant for the category
Qualified Institutional Buyers (QIBs)
Non Institutional Investors
Retail Individual Investors(RIIs)



Important dates for Metropolis Healthcare Limited IPO Allotment Status

Metropolis Healthcare Limited IPO allotment status would be available soon after the IPO closure date. Usually the allotment comes within a week from the closing date which in this IPO yet to be announced. Important Tantatives dates for Metropolis Healthcare Limited IPO are:

  • The Allotment date for Metropolis Healthcare Limited IPO issue is expected on Apr 12,2019
  • The amount will get unblocked on Apr 15, 2019
  • The Shares are expected to credit in DP accounts on Apr 15, 2019
  • The Shares of Metropolis Healthcare Limited is likely to get listed on Apr 16,2019 on both BSE and NSE.


Get Stock Market Recommendation By Our Research Analysts Starting Just Rs. 2000/-



Check Metropolis Healthcare Limited  IPO Allotment Status

Metropolis Healthcare Limited IPO allotment status would be available soon after the IPO closure date. Usually the allotment comes within a week from the closing date which in this IPO yet to be announced.

One can check the allotment on the given below link with PAN number or Application number or DP Client Id. All you need to do is to follow these steps:-

  1. To Check  Metropolis Healthcare  Limited  IPO Allotment Status
  2. Go to Application Status
  3. Select IPO as Metropolis Healthcare Limited
  4. Enter your PAN Number or Application Id or DP Client Id.

It takes little time to fetch information so you need to be little patient.

Download “Metropolis Healthcare Limited” IPO Application Form

From BSE: click here

Open Your Demat Account to Invest in Upcoming IPO’s


Promoters Of The Company:-




Financials:- (Restated Consolidated Financial Record)

Particulars For the year/Period ended (Rs. in Millions)
Financial Year 31-Mar-18 31-Mar-17 31-Mar-16
Total Equity & Liabilities 5,303.39 5,151.58 3,959.15
Total Revenue 6,515.55 5,676.59 4,906.34
Total Expenses 4,912.54 4,103.91 3,664.22
Profit After Tax (PAT) 1,097.47 1,072.57 819.55


Lead Manager Details:-

1) JM Financial Limited

7 th Floor, Cnergy Appasaheb Marathe Marg Prabhadevi

Mumbai 400 025

Tel: (91 22) 6630 3030

Facsimile: (91 22) 6630 3330


Investor Grievance Email:


Contact Person: Prachee Dhuri

SEBI Registration Number: INM000010361

2) Credit Suisse Securities (India) Private Limited^

9 th Floor, Ceejay House Dr. Annie Besant Road, Worli,

Mumbai 400 018

Tel: (91 22) 6777 3885

Facsimile: (91 22) 6777 3820


Investor Grievance Email:


Contact Person: Akshay Lulla

SEBI Registration Number: INM000011161

3) Goldman Sachs (India) Securities Private Limited

Rational House 951-A,

Appasaheb Marathe Marg, Prabhadevi

Mumbai 400 025 Tel: (91 22) 6616 9000

Facsimile: (91 22) 6616 9001


Investor Grievance Email:


Contact Person: Sonam Chopra

SEBI Registration Number: INM000011054

4) HDFC Bank Limited Investment Banking Group

Unit No. 401 & 402,

4th Floor Tower B, Peninsula Business Park, Lower Parel

Mumbai 400 013

Tel: (91 22) 3395 8233

Facsimile: (91 22) 3078 8584


Investor Grievance e-mail:


Contact Person: Rakesh Bhunatar/Ravi Sharma

SEBI Registration No.: INM000011252

5) Kotak Mahindra Capital Company Limited

1 st Floor, 27 BKC, Plot No. 27 G Block,

Bandra Kurla Complex Bandra (East)

Mumbai 400 051

Tel: (91 22) 4336 0000

Facsimile: (91 22) 6713 2447


Investor Grievance Email:


Contact Person: Ganesh Rane

SEBI Registration Number: INM000008704


Registrar To The Issue:-

Link Intime India Private Limited C-101,

1st floor, 247 Park L B S Marg Vikhroli

West Mumbai 400 083

Tel: (91 22) 4918 6200

Facsimile: (91 22) 4918 6195


Investor grievance e-mail:


Contact Person: Shanti Gopalkrishnan

SEBI Registration No.: INR000004058


Registered Office Details:-

250 D Udyog Bhavan, Hind Cycle Marg,

Worli, Mumbai 400 030,

Maharashtra, India;

Tel: (91 22) 6258 2810

Facsimile: Not available Contact Person: Jayant Prakash,

Head Legal, Company Secretary and Compliance Officer;



Corporate Identity Number: U73100MH2000PLC192798

For More Details Contact us 011-42445800 / 9650901058


To Invest in IPO, Submit Your Details Below:

[contact-form-7 404 "Not Found"]